(Photo credit: Wikipedia)
A new way to make powerful changes at will to the DNA of humans, other animals and plants, much like how a writer changes words in a story, could usher in a transformation in genetic medicine.
Scientists are not just excited about this recently discovered technique because it can snip and edit DNA with precision. It can also do the job more easily and cheaply than other gene-editing methods, making possible research that has historically been difficult, experts say.
Now some of the biologists who unlocked this tool, derived from the immune system of bacteria, are forming companies around it. Although this molecular system, known as Crispr, is not fully understood, researchers believe it can be harnessed to create therapies for intractable genetic diseases.
“In principle, this is a technology that could enable correction of genetic mutations that would otherwise lead to disease,” said Doudna, a professor of chemistry and biochemistry and molecular biology, in a telephone interview. She was among several experts who spoke at a UC Berkeley conference on the subject last month.
Ethical concerns
But because the method is in its infancy and has little precedent with the agencies that regulate medicines, it will almost certainly be a long time before a Crispr-based therapy makes it to market.
Its potential risks also concern some bioethicists.
The Latest on: Editing DNA
via Google News
The Latest on: Editing DNA
- How a New Biotech Rule Will Impede Progress in Scienceon June 2, 2020 at 5:11 pm
The exemption of many gene-edited crops from government oversight reflects the lack of accountability and trust between the public and government agencies setting policies.
- New advance addresses a big challenge with using CRISPR in cancer patientson June 2, 2020 at 4:51 pm
A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring ...
- New CRISPR advance may solve key quandaryon June 2, 2020 at 1:02 pm
A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring ...
- Substitution of warthog NF-κB motifs into RELA of domestic pigs is not sufficient to confer resilience to African swine fever viruson June 2, 2020 at 2:37 am
African swine fever virus (ASFV) causes a lethal, haemorrhagic disease in domestic swine that threatens pig production across the globe. Unlike domestic pigs, warthogs, which are wildlife hosts of the ...
- Left-Handed DNA Has a Biological Role Within a Dynamic Genetic Codeon June 1, 2020 at 12:24 am
I n 1970, biochemist Robert Wells of the University of Alabama at Birmingham saw something strange in his X-ray images of a new synthetic DNA poly ...
- Researchers hope CRISPR gene-editing technology can yield rapid at-home COVID-19 teston May 29, 2020 at 4:42 pm
Researchers in the U.S. are using the gene-editing technology known as CRISPR to develop a COVID-19 testing kit they say will be used quickly and easily at home, at roughly the same price as a common ...
- Gene-editing patents have increased tenfold in just four years. Here’s what the technology could cureon May 26, 2020 at 4:00 am
CRISPR gene-editing trials have taken off—and may hold the key to medical breakthroughs.
- Covid-19 and gene editing: ethical and legal considerationson May 25, 2020 at 2:43 am
Researchers are racing against time to find ways to treat and prevent Covid-19. There is currently no treatment for the disease, and the World Health Organisation has created Solidarity, a global ...
- Mike Kamdar, The Future Of DNA Writing, And The Business Of Biologyon May 23, 2020 at 5:06 am
With a new way to write DNA, Mike Kamdar and his team at Molecular Assemblies are poised to disrupt just about any industry you can imagine.
- Outlook on the Worldwide Genome Editing Industry to 2025 - Featuring Pfizer, Bayer Crop Science & Editas Medicine Among Others - ResearchAndMarkets.comon May 22, 2020 at 5:02 am
Featuring Pfizer, Bayer Crop Science & Editas Medicine Among Others - ResearchAndMarkets.com DUBLIN-- ( BUSINESS WIRE )--The "Global Genome Editing Market By Technique (CRISPR, Zinc Finger Nucleases, ...
via Bing News
